The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are proud to present the Ninth International Cancer lmmunotherapy Conference CICON25 in Utrecht, September 10-12, 2025.
Read MoreACIR has published an extensive special feature covering select talks from the the 22nd CIMT Annual Meeting in Mainz, Germany, May 12-14, 2025.
Read MoreThe 22nd CIMT Annual Meeting opened today in Mainz, Germany. Over the coming days, researchers and IO developers from 30 countries are coming together to share the latest advances in cancer immunotherapy.
Read MoreThe CIMT Members Meeting will take place on May 12, 2025, 12:30-13:30 as part of the 22nd CIMT Annual Meeting.
Read MoreThe Swedish researcher Rolf Kiessling has been selected as the recipient of the 2025 CIMT Lifetime Achievment Award. The award will be presented on the evening of Tuesday, May 13, at 6 p.m., during the 22nd CIMT Annual Meeting in Mainz, Germany.
Read MoreDue to high activity on our abstract submission platform, we have extended the CIMT Annual Meeting abstract deadline!
New submission deadline: March 14 (midnight CET)
We are excited to announce that registration and abstract submission for the 22nd CIMT Annual Meeting are now open. Submit your abstract and present your research in Mainz, Germany, May 12-14, 2025 . Find more information at www.meeting.cimt.eu
Read MoreThe 2025 CIMT Annual Meeting will take place May 12-14, 2025, in Mainz, Germany. Abstract submission and registration will open in early January 2025. The meeting will explore key topics such as Improving Immunity, Tumor Microenvironment, New Targets, Cellular Therapies, Artificial Intelligence, and the emerging field of Neuro-Oncoimmunology.
Read MoreThe CRI-ENCI Eighth International Cancer Immunotherapy Conference (CICON24) opened today at the Gaylord National Resort and Convention Center in National Harbor, Maryland.
Read More